206536-69-8Relevant articles and documents
Use of a pharmacophore model for the design of EGFR tyrosine kinase inhibitors: Isoflavones and 3-phenyl-4(1H)-quinolones
Traxler, Peter,Green, Jennifer,Mett, Helmut,Séquin, Urs,Furet, Pascal
, p. 1018 - 1026 (1999)
Using a pharmacophore model for ATP-competitive inhibitors interacting with the active site of the EGFR protein tyrosine kinase together with published X-ray crystal data of quercetin (2) in complex with the Hck tyrosine kinase and of deschloroflavopirido